Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HG Capital offloads Argus Media stake for £52m

(Sharecast News) - Private equity group HgCapital on Monday said it had offloaded its stake in oil pricing data publisher Argus Media, allowing chief executive Adrian Binks to take a majority stake in the firm. The deal values HgCapital's investment in Argus £52m. Existing minority shareholder General Atlantic - another private equity outfit - will also buy part of Hg's stake.

Founded in 1970 and headquartered in London, Argus serves more than 11,000 customers globally providing price assessments, news, analytics, consulting services, data science tools, and industry conferences to the global energy and commodities markets.

General Atlantic is a long-term partner to Argus, having initially bought its shares in 2016. Hg bought half of General Atlantic's stake four years ago.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Yellow Cake NAV slips as uranium values decline
(Sharecast News) - Uranium investor Yellow Cake reported a rise in uranium holdings but a decrease in net asset value due to lower spot prices in its interim results on Tuesday.
Digitalbox FY EBITDA now seen ahead of internal expectations
(Sharecast News) - Digital media business Digtalbox said on Tuesday that it now expects FY24 revenues to be at least £3.5m, while underlying earnings were also seen ahead of management's expectations.
Dianomi expects to record small loss in FY24
(Sharecast News) - Digital advertising business Dianomi warned on Tuesday that it and to record a small loss in FY24 compared to market expectations of a small profit.
Ixico secures new contract with US-based client
(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.